Senior insider sale
President and CEO at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$537.5K
34.86K shares
What this filing means
WEBER CHRISTOPHE PIERRE plans to sell 34.86K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $537.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2025ACC: 0002011270-25-000004
DirectorOfficer· President and CEO
Since Mar 2026
34.86K
Shares to sell
$537.5K
Approx. market value
68.66K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2025
68.66KTotal acquired68.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2025 | Restricted Stock Unit Awards - Vested. Compensation | 68.66K | — |
| Total | 68.66K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
34.86K
Market value
$537.5K
7/9/2025
Total
Units
34.86K
Value
$537.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/9/2025 | 34.86K | $537.5K | NYSE | Planned |
| Total | 34.86K | $537.5K | ||